Business

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice SuccessNEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the Music City SCALE meeting taking place May 13-17 in Nashville, TN. Results from a 12-Week Open-Label Study Evaluating the Efficacy and Tolerability of Obagi NU-GEN Cellular Re

articleWaldencast PlcMay 15, 20263/company/waldencast-acquisition-corp/news/obagi-medical-shares-new-data-on-recent-innovations-at-music-city-symposium-for-cosmetic-advances-and-laser-education-scale-meeting
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

About this update from Waldencast Plc

[{"type":"image","alt":"Waldencast plc","displaySize":"","headline":null,"caption":"Waldencast plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":37,"url":"https://media.zenfs.com/en/globenewswire.com/21d8976473fad764236ddecc2f0e6a18"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/F8WfScV14mV_DVfed7dUCA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUy/https://media.zenfs.com/en/globenewswire.com/21d8976473fad764236ddecc2f0e6a18","width":300,"height":37},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/F8WfScV14mV_DVfed7dUCA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUy/https://media.zenfs.com/en/globenewswire.com/21d8976473fad764236ddecc2f0e6a18","width":300,"height":37}},"lazy":false},{"type":"text","content":"Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice Success","length":110,"tagName":"p"},{"type":"text","content":"NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the Music City SCALE meeting taking place May 13-17 in Nashville, TN.","length":281,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Results from a 12-Week Open-Label Study Evaluating the Efficacy and Tolerability of Obagi NU-GEN Cellular Renewal Serum on Wrinkles, Hyperpigmentation, Radiance, Texture, Firmness, Plumpness, and Perceived Skin Age: ePoster Dr. Todd Schlessinger, MD","length":249,"tagName":"p"}]},{"val":[{"type":"text","content":"Interim Results from a large scale Multiple Practitioner Real-World Evaluation of a Novel Hyaluronic Acid Dermal Filler in Conjunction with Medical Grade Skin Care: ePoster Dr. Carolyn Jacob, MD ","length":194,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":443,"olType":false},{"type":"text","content":"“As one of the pivotal clinical sites for the FDA registration programs for the Obagi fillers, I was intrigued to do a real-world evaluation of Obagi Saypha® MagIQ™,” said Dr. Carolyn Jacob, MD. “Reviewing the results from over 300 participating sites validated the core clinical results and makes it clear that there is a place for MagIQ in most practices.”","length":358,"tagName":"p"},{"type":"text","content":"The real-world data evaluated an interim review of the ALOHA (...

More updates from Waldencast Plc

Obagi MedicalObagi skincareObagi Medical productsCarolyn JacobNU-GENaesthetic solutionsReal-World EvaluationMedical Grade Skin CareMusic City SCALEclinical resultsskin discolorationMagIQ